# A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

> **NCT00658515** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 15871 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Dalcetrapib (RO4607381)
- **DRUG:** Evidence-based medical care for Acute Coronary Syndrome
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00658515
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 15871 (ACTUAL)
- **Last updated:** 2020-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00658515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00658515, "A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT00658515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*